Macfarlanes advises Caledonia Investments on sale of stake in BioAgilytix to Cinven and subsequent re-investment
Caledonia have re-invested $42m from the proceeds back into BioAgilytix, alongside current majority investor Cobepa and a consortium of other sponsors.
The Macfarlanes team was led by corporate and M&A partner Stephen Drewitt alongside senior solicitor Nicholas Page.